3 studies found for: "Hepatocellular carcinoma (fibrolamellar variant)"
|1||Not yet recruiting||
A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma
† Indicates status has not been verified in more than two years